Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies
Abstract Objective Episodes of major depressive disorder (MDD) characterized by high levels of anxiety symptoms are less likely to respond